Country websites

Shaping the future of kidney care

Facts & Figures 2023

Who we are

Creating a future worth living. For patients. Worldwide. Every day.

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which approximately 4.1 million patients worldwide regularly undergo dialysis treatment. United by a shared purpose of creating a future worth living for chronically and critically ill people, we care for more than 332,000 dialysis patients around the globe. Their well-being always comes first.

It is our mission to provide the best possible care for a growing number of patients sustainably in diverse health care systems. As a vertically integrated company, our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis.

employees worldwide

Around

120,000

employees worldwide

dialysis centers in around 50 countries

Around

4,000

dialysis centers in around 50 countries

Products in around

Products in around

150

countries

dialysis treatments in 2023

Around

52 M

dialysis treatments in 2023

patients worldwide

More than

332,000

patients worldwide

of our patients would highly recommend our services

78 %

of our patients would highly recommend

our services

production sites in around 20 countries

Around

40

production sites in around 20 countries

dialyzers sold in 2023

Around

165 M

dialyzers sold in 2023

share in hemodialysis machines market

Around

50 %

share in hemodialysis machines market

Shaping the future of kidney care

2023 was a year full of fundamental transformation that we successfully mastered as a company. We are proud of our achievements and have laid the foundation for sustainable profitable growth, and to continue meeting our high standards in shaping the future of kidney care for the benefit of our patients.

Helen Giza Chief Executive Officer

In 2023, we delivered on our commitments while we fundamentally transformed Fresenius Medical Care. Exceeding our upgraded financial outlook for the full year was the very successful finish to an extraordinary year. We implemented the new global operating model, progressed on our operational turnaround ambitions, changed our legal form and advanced on the Portfolio Optimization Program through key divestments. Thanks to the commitment of our 120,000 employees, the high quality of care for our patients remains front and center in everything we do.

Helen Giza

Chief Executive Officer and Chair of the Management Board

Revenue

Solid organic growth

Revenue Solid organic growth

Operating income

Exceeding top end of outlook range

Operating income

Net Income

Growth driven by favorable business development

Growth driven by favorable business development

Dividend per share

Dividend per share

Download - Annual Report

Download our Annual Report and get detailed information about our fiscal year 2023.

Download – Non-financial Group Report

Download our Non-financial Group report and get an overview of our sustainability efforts in the 2023 fiscal year.